| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Lipocine Inc (NASDAQ: LPCN)
LPCN Technical Analysis
4
| As on 13th Jun 2025 LPCN STOCK Price closed @ 3.12 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.02 & Sell for SHORT-TERM with Stoploss of 3.61 we also expect STOCK to react on Following IMPORTANT LEVELS. |
LPCNSTOCK Price
| Open | 3.10 | Change | Price | % |
| High | 3.19 | 1 Day | -0.04 | -1.27 |
| Low | 3.05 | 1 Week | -0.08 | -2.50 |
| Close | 3.12 | 1 Month | -0.44 | -12.36 |
| Volume | 12166 | 1 Year | 0.19 | 6.48 |
| 52 Week High 10.69 | 52 Week Low 2.79 | ||||
NASDAQ USA Most Active Stocks
| HCTI | 0.02 | -33.33% |
| GNLN | 0.01 | -50.00% |
| AMRS | 0.14 | 100.00% |
| NVDA | 141.97 | -2.09% |
| TSLA | 325.31 | 1.94% |
| LMDX | 0.02 | 0.00% |
| NCNA | 0.11 | -26.67% |
| USEG | 2.21 | 55.63% |
| AKTS | 0.04 | 0.00% |
| LCID | 2.10 | -2.78% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| LPCN Daily Charts |
LPCN Intraday Charts |
Whats New @ Bazaartrend |
LPCN Free Analysis |
|
|
LPCN Important Levels Intraday
| RESISTANCE | 3.39 |
| RESISTANCE | 3.30 |
| RESISTANCE | 3.25 |
| RESISTANCE | 3.20 |
| SUPPORT | 3.04 |
| SUPPORT | 2.99 |
| SUPPORT | 2.94 |
| SUPPORT | 2.85 |
LPCN Forecast June 2025
| 4th UP Forecast | 6.03 |
| 3rd UP Forecast | 5.1 |
| 2nd UP Forecast | 4.52 |
| 1st UP Forecast | 3.94 |
| 1st DOWN Forecast | 2.3 |
| 2nd DOWN Forecast | 1.72 |
| 3rd DOWN Forecast | 1.14 |
| 4th DOWN Forecast | 0.21 |
LPCN Weekly Forecast
| 4th UP Forecast | 3.66 |
| 3rd UP Forecast | 3.49 |
| 2nd UP Forecast | 3.38 |
| 1st UP Forecast | 3.27 |
| 1st DOWN Forecast | 2.97 |
| 2nd DOWN Forecast | 2.86 |
| 3rd DOWN Forecast | 2.75 |
| 4th DOWN Forecast | 2.58 |
LPCN Forecast2025
| 4th UP Forecast | 21.14 |
| 3rd UP Forecast | 15.36 |
| 2nd UP Forecast | 11.79 |
| 1st UP Forecast | 8.22 |
| 1st DOWN Forecast | -1.98 |
| 2nd DOWN Forecast | -5.55 |
| 3rd DOWN Forecast | -9.12 |
| 4th DOWN Forecast | -14.9 |
Lipocine Inc ( NASDAQ USA Symbol : LPCN )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
LPCN Business Profile
Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of metabolic and endocrine disorders. Its primary development programs are based on oral delivery solutions for poorly bioavailable drugs. The company has a portfolio of product candidates designed to produce pharmacokinetic characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's pipeline candidates also include LPCN 1144, an oral prodrug of bioidentical testosterone that is in Phase II Clinical trial for the treatment of non-cirrhotic non-alcoholic steatohepatitis (NASH); TLANDO XR, an oral prodrug of testosterone for once daily dosing, which has completed Phase II clinical trial in hypogonadal men; LPCN 1148, an oral prodrug of bioidentical testosterone that has completed phase I clinical trial for the treatment of NASH cirrhosis; and LPCN 1107, an oral hydroxyprogesterone caproate product that has completed dose finding Phase II clinical trial for the prevention of recurrent preterm birth. The company is headquartered in Salt Lake City, Utah. Address: 675 Arapeen Drive, Salt Lake City, UT, United States, 84108
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service